Remab Therapeutics
Developing a pipeline with different indications.
Launch date
Employees
Company register number B67210021
L'Hospitalet de Llobregat Catalonia (HQ)
Financials
Estimates*
EUR | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m |
% growth | - | 198 % | 227 % | 17 % |
EBITDA | - | <1m | <1m | <1m |
% EBITDA margin | - | 7 % | 7 % | 9 % |
Profit | - | - | - | (<1m) |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
€70.0k | Grant | ||
N/A | Spinout | ||
€35.0k | Grant | ||
€50.0k | Grant | ||
Total Funding | CAD233k |
Related Content
Recent News about Remab Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.